Inspire Medical Systems, Inc. (INSP)
After hours:
| Previous close | 144.26 |
| Open | 144.27 |
| Bid | 144.56 x 900 |
| Ask | 153.83 x 1200 |
| Day's range | 140.00 - 145.82 |
| 52-week range | 123.27 - 330.00 |
| Volume | |
| Avg. volume | 733,637 |
| Market cap | 4.29B |
| Beta (5Y monthly) | 1.47 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.10 |
| Earnings date | 05 Feb 2024 - 09 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 212.67 |
Zacks3 Reasons to Retain Inspire Medical (INSP) Stock for Now
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
GlobeNewswireInspire Medical Systems, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
MINNEAPOLIS, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023. Inspire is scheduled to present at 2:00 p.m. Eastern Time. The presentation will be accessible
Insider MonkeyInspire Medical Systems (INSP) Fell on Fears Relating to Increasing Adoption of Weight Loss Drugs
Headwaters Capital Management, an investment management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund declined -7.6% (-7.8% net) in the third quarter compared to a -4.7% return for the Russell Mid Cap Index. The YTD results stand at +14.2% (+13.5% net) compared to a +3.9% […]
